Testing laboratories, Business management consultant, Medical research
Apath
Apath, LLC is a New York-based company specializing in the development and licensing of innovative technologies for the screening and research of Hepatitis C Virus (HCV). With a diverse portfolio of HCV-related intellectual property, Apath offers sublicensing opportunities and access to cutting-edge research tools, providing clients with comprehensive solutions for anti-HCV development. Through collaborations with renowned institutions such as The Rockefeller University and The University of Copenhagen, Apath expands its technology portfolio, offering full virus screening systems, replicon technologies, cell lines, and reporter viruses. With a team of experienced virologists, Apath is committed to providing clients with exceptional development platforms and research tools to advance the fight against Hepatitis C.Generated from the website